Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Biotechnology

Collaboration

Health Care

Therapeutics

Adimab

Adimab's headquarters in Lebanon, NH, United States

Philip Chase

Aaron Sato

Marianne Huger Thomson

Amy Bray

Guy Van Meter

Ryan McGovern

Eric Krauland

Tillman U. Gerngross

The Research and Development team at Adimab is dedicated to advancing antibody discovery and optimization through cutting-edge research and innovative methodologies. Comprised of a diverse group of scientists and research associates, the team focuses on engineering full-length human Immunoglobulin Gs, employing techniques in protein analytics, computational biology, and bioprocess engineering to enhance the efficacy and performance of therapeutic antibodies. Their collaborative efforts drive the continuous improvement of antibody technologies to meet the evolving needs of the biopharmaceutical industry.

Research and Development

This department conducts scientific studies and analyzes data to support various research initiatives.

Research Department

This department focuses on cultivating leadership skills and advancing management capabilities within the organization.

Leadership Development

This department focuses on conducting research activities and supporting advanced studies in various academic fields.

Research Associates

This department focuses on the development and research of antibody technologies and engineering processes.

Antibody Engineering

This department focuses on creating and maintaining software applications and systems.

Adimab

Org chart

Board & advisors

Teams

Research and Development

Research Department

Leadership Development

Research Associates

Antibody Engineering

Software Development

Offices

Adimab

Org chart

Board & advisors

Teams

Research and Development

Research Department

Leadership Development

Research Associates

Antibody Engineering

Software Development

Offices

Related companies